PCVX

Vaxcyte
D

PCVX

48.730
USD
1.78
(3.79%)
مغلق
حجم التداول
49,817
الربح لكل سهم
-4
العائد الربحي
-
P/E
-7
حجم السوق
7,036,499,044
المقالات
المزيد

العنوان: Vaxcyte

القطاع: Healthcare
الصناعة: Biotechnology
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.